Muller Fabbri to Clinical Trials as Topic
This is a "connection" page, showing publications Muller Fabbri has written about Clinical Trials as Topic.
Connection Strength
0.190
-
Fabbri M. Natural Killer Cell-Derived Vesicular miRNAs: A New Anticancer Approach? Cancer Res. 2020 01 01; 80(1):17-22.
Score: 0.158
-
Giza DE, Fuentes-Mattei E, Bullock MD, Tudor S, Goblirsch MJ, Fabbri M, Lupu F, Yeung SJ, Vasilescu C, Calin GA. Cellular and viral microRNAs in sepsis: mechanisms of action and clinical applications. Cell Death Differ. 2016 12; 23(12):1906-1918.
Score: 0.032